Video Shorts

One Supply Chain Trend to Watch In 2027

AI Spoofing: A Supply Chain Risk for 2027

How IRA Negotiation, Tariffs and MFN Converge on Drug Prices

Is Pharma's Operating Model Being Rewritten?

Valerie Bandy on the Challenges Behind 340B Rebates

The Complexities of 340B Rebate Tracking

Gregg Gorniak on Turning DSCSA Compliance Into Strategic Opportunity

How Distributors Should Prepare for National Licensure

How Pharma Will Navigate the NDC-12 Transition

How A National Licensure Standard Would Change Wholesaler Operations

How AI and RFID Boosts Supply Chain Visibility

What's the Reality for Independent Pharmacies?

How Disparate PV Systems Stall Drug Launches

Could the US Reshore Generics?

Penny for Your Thoughts: Episode 16

Does TrumpRx's Rhetoric Match Actual Patient Savings?

Is TrumpRx Delivering Savings for Patients?

Can Data Prevent the Next Drug Shortage?

Penny for Your Thoughts: Episode 15

How Has Direct-to-Patient Played Out in H1?

Is Patient Affordability Better or Worse in 2026?

What the US Tariff Inquiry Into Germany Signals for pharma

Penny for Your Thoughts: Episode 14

Is Direct the Future of Commercialization?

How Patient Data from DTP Models Shape Commercial Decisions

What's Driving Direct-to-Patient Model Adoption Across Pharma?

What's Standing Between Reshoring Ambitions and Reality?

How Can Pharma Prepare for Potential USMCA Changes?

Could PBM Reform Actually Lower Net Drug Costs?

Why Aren't More Payers Using RWE?